| pubmed-article:11753165 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11753165 | lifeskim:mentions | umls-concept:C0008059 | lld:lifeskim |
| pubmed-article:11753165 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
| pubmed-article:11753165 | lifeskim:mentions | umls-concept:C0021747 | lld:lifeskim |
| pubmed-article:11753165 | lifeskim:mentions | umls-concept:C0524910 | lld:lifeskim |
| pubmed-article:11753165 | lifeskim:mentions | umls-concept:C0034037 | lld:lifeskim |
| pubmed-article:11753165 | lifeskim:mentions | umls-concept:C1704324 | lld:lifeskim |
| pubmed-article:11753165 | lifeskim:mentions | umls-concept:C0936012 | lld:lifeskim |
| pubmed-article:11753165 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:11753165 | pubmed:dateCreated | 2001-12-25 | lld:pubmed |
| pubmed-article:11753165 | pubmed:abstractText | Although no therapeutic regimen has received Food and Drug Administration approval for treating children with chronic hepatitis C viral infection (CHC), there have been a number of pediatric interferon-alpha (IFN-alpha) trials. The purpose of this study was to perform a critical review of these trials to determine 1) end-of-treatment (ETR) and sustained-response (SR) rates, 2) predictors of response to therapy, and 3) safety of and tolerance to IFN-alpha in children with CHC. | lld:pubmed |
| pubmed-article:11753165 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11753165 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11753165 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11753165 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:11753165 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11753165 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11753165 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11753165 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11753165 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:11753165 | pubmed:issn | 0277-2116 | lld:pubmed |
| pubmed-article:11753165 | pubmed:author | pubmed-author:JacobsonKaren... | lld:pubmed |
| pubmed-article:11753165 | pubmed:author | pubmed-author:MurrayKarenK | lld:pubmed |
| pubmed-article:11753165 | pubmed:author | pubmed-author:ZellosAglaiaA | lld:pubmed |
| pubmed-article:11753165 | pubmed:author | pubmed-author:SchwarzKathle... | lld:pubmed |
| pubmed-article:11753165 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11753165 | pubmed:volume | 34 | lld:pubmed |
| pubmed-article:11753165 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11753165 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11753165 | pubmed:pagination | 52-8 | lld:pubmed |
| pubmed-article:11753165 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:11753165 | pubmed:meshHeading | pubmed-meshheading:11753165... | lld:pubmed |
| pubmed-article:11753165 | pubmed:meshHeading | pubmed-meshheading:11753165... | lld:pubmed |
| pubmed-article:11753165 | pubmed:meshHeading | pubmed-meshheading:11753165... | lld:pubmed |
| pubmed-article:11753165 | pubmed:meshHeading | pubmed-meshheading:11753165... | lld:pubmed |
| pubmed-article:11753165 | pubmed:meshHeading | pubmed-meshheading:11753165... | lld:pubmed |
| pubmed-article:11753165 | pubmed:meshHeading | pubmed-meshheading:11753165... | lld:pubmed |
| pubmed-article:11753165 | pubmed:meshHeading | pubmed-meshheading:11753165... | lld:pubmed |
| pubmed-article:11753165 | pubmed:meshHeading | pubmed-meshheading:11753165... | lld:pubmed |
| pubmed-article:11753165 | pubmed:meshHeading | pubmed-meshheading:11753165... | lld:pubmed |
| pubmed-article:11753165 | pubmed:meshHeading | pubmed-meshheading:11753165... | lld:pubmed |
| pubmed-article:11753165 | pubmed:meshHeading | pubmed-meshheading:11753165... | lld:pubmed |
| pubmed-article:11753165 | pubmed:meshHeading | pubmed-meshheading:11753165... | lld:pubmed |
| pubmed-article:11753165 | pubmed:meshHeading | pubmed-meshheading:11753165... | lld:pubmed |
| pubmed-article:11753165 | pubmed:meshHeading | pubmed-meshheading:11753165... | lld:pubmed |
| pubmed-article:11753165 | pubmed:meshHeading | pubmed-meshheading:11753165... | lld:pubmed |
| pubmed-article:11753165 | pubmed:meshHeading | pubmed-meshheading:11753165... | lld:pubmed |
| pubmed-article:11753165 | pubmed:meshHeading | pubmed-meshheading:11753165... | lld:pubmed |
| pubmed-article:11753165 | pubmed:meshHeading | pubmed-meshheading:11753165... | lld:pubmed |
| pubmed-article:11753165 | pubmed:year | 2002 | lld:pubmed |
| pubmed-article:11753165 | pubmed:articleTitle | An analysis of published trials of interferon monotherapy in children with chronic hepatitis C. | lld:pubmed |
| pubmed-article:11753165 | pubmed:affiliation | Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. | lld:pubmed |
| pubmed-article:11753165 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:11753165 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:11753165 | pubmed:publicationType | Meta-Analysis | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11753165 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11753165 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11753165 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11753165 | lld:pubmed |
